Yanjiao Lu

418 total citations
22 papers, 314 citations indexed

About

Yanjiao Lu is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Yanjiao Lu has authored 22 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 5 papers in Molecular Biology. Recurrent topics in Yanjiao Lu's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Asthma and respiratory diseases (5 papers) and Sarcoidosis and Beryllium Toxicity Research (3 papers). Yanjiao Lu is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Asthma and respiratory diseases (5 papers) and Sarcoidosis and Beryllium Toxicity Research (3 papers). Yanjiao Lu collaborates with scholars based in China, Canada and Australia. Yanjiao Lu's co-authors include Jianping Zhao, Shanshan Wang, Jungang Xie, Meijia Wang, Kun Tang, Zhen‐Li Huang, Pengfei Gao, Chung‐Yi Hu, Weiping Zou and Congcong Yu and has published in prestigious journals such as Circulation, Nature Methods and Ophthalmology.

In The Last Decade

Yanjiao Lu

21 papers receiving 308 citations

Peers

Yanjiao Lu
Melissa Gans United States
Xun Gao China
Jinyan Yu China
Ahmed A. Abokor United States
Mira Mousa United Arab Emirates
Irma Joosten Netherlands
Lan Cui China
Yanjiao Lu
Citations per year, relative to Yanjiao Lu Yanjiao Lu (= 1×) peers Prasanta Padhan

Countries citing papers authored by Yanjiao Lu

Since Specialization
Citations

This map shows the geographic impact of Yanjiao Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanjiao Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanjiao Lu more than expected).

Fields of papers citing papers by Yanjiao Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanjiao Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanjiao Lu. The network helps show where Yanjiao Lu may publish in the future.

Co-authorship network of co-authors of Yanjiao Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanjiao Lu. A scholar is included among the top collaborators of Yanjiao Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanjiao Lu. Yanjiao Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Chengwei, Xinyu Du, Yanjiao Lu, et al.. (2025). Integrating diverse experimental information to assist protein complex structure prediction by GRASP. Nature Methods. 22(11). 2362–2374. 1 indexed citations
3.
Gao, Pengfei, Yanjiao Lu, Kun Tang, et al.. (2024). Ficolin-1 ameliorates pulmonary fibrosis via directly binding to TGF-β1. Journal of Translational Medicine. 22(1). 1051–1051. 1 indexed citations
4.
Lu, Yanjiao, et al.. (2024). Effect of Different Interventions on Lumbar Spinal Stenosis: A Systematic Evaluation and Network Meta-Analysis. World Neurosurgery. 194. 123459–123459. 1 indexed citations
5.
Gao, Pengfei, Kun Tang, Yanjiao Lu, et al.. (2023). Increased expression of ficolin-1 is associated with airway obstruction in asthma. BMC Pulmonary Medicine. 23(1). 470–470. 4 indexed citations
6.
Lu, Yanjiao, Shanshan Wang, Zhen Tian, et al.. (2023). Dach1 deficiency drives alveolar epithelium apoptosis in pulmonary fibrosis via modulating C-Jun/Bim activity. Translational research. 257. 54–65. 10 indexed citations
7.
Wang, Shanshan, Yanjiao Lu, Zhen‐Li Huang, et al.. (2023). Sphingosine-1-Phosphate Receptor 4 Attenuates Neutrophilic Airway Inflammation in Experimental Asthma via Repressing Proinflammatory Macrophage Activation. International Journal of Biological Sciences. 19(5). 1597–1615. 13 indexed citations
8.
Wan, Yi, Fang Zeng, Haoyu Tan, et al.. (2022). Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review. Osteoporosis International. 33(5). 979–1015. 18 indexed citations
9.
Lu, Yanjiao, Jinkun Chen, Shanshan Wang, et al.. (2021). Identification of Genetic Signature Associated With Aging in Pulmonary Fibrosis. Frontiers in Medicine. 8. 744239–744239. 7 indexed citations
10.
Lu, Yanjiao, Zhen‐Li Huang, Meijia Wang, et al.. (2021). Clinical characteristics and predictors of mortality in young adults with severe COVID-19: a retrospective observational study. Annals of Clinical Microbiology and Antimicrobials. 20(1). 3–3. 21 indexed citations
11.
Lu, Yanjiao, Jinkun Chen, Kun Tang, et al.. (2021). Development and Validation of the Prognostic Index Based on Inflammation-Related Gene Analysis in Idiopathic Pulmonary Fibrosis. Frontiers in Molecular Biosciences. 8. 667459–667459. 4 indexed citations
12.
Wang, Shanshan, Kun Tang, Yanjiao Lu, et al.. (2020). Revealing the role of glycerophospholipid metabolism in asthma through plasma lipidomics. Clinica Chimica Acta. 513. 34–42. 56 indexed citations
13.
Gao, Pengfei, Kun Tang, Yanjiao Lu, et al.. (2020). Pentraxin 3 promotes airway inflammation in experimental asthma. Respiratory Research. 21(1). 237–237. 24 indexed citations
14.
Wang, Xinghuan, Wei Liu, Jianping Zhao, et al.. (2020). Clinical characteristics of 80 hospitalized frontline medical workers infected with COVID-19 in Wuhan, China. Journal of Hospital Infection. 105(3). 399–403. 48 indexed citations
15.
Guan, Xuewa, Yanjiao Lu, Guoqiang Wang, et al.. (2018). The Role of Regulatory T Cell in Nontypeable Haemophilus influenzae-Induced Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Mediators of Inflammation. 2018. 1–14. 14 indexed citations
16.
Dong, Zhiyong, Weijie Zhang, Peter G. Gibson, et al.. (2016). Holding the Inflammatory System in Check: TLRs and Their Targeted Therapy in Asthma. Mediators of Inflammation. 2016. 1–8. 24 indexed citations
17.
Lu, Yanjiao, Yanshen Li, Rui Yao, et al.. (2016). Clinical effect of ticagrelor administered in acute coronary syndrome patients following percutaneous coronary intervention. Experimental and Therapeutic Medicine. 11(6). 2177–2184. 6 indexed citations
18.
Zheng, Jingtong, Yanjiao Lu, Guoqiang Wang, et al.. (2016). Protective Effect of Yinhua Miyanling Tablet on Lipopolysaccharide‐Induced Inflammation through Suppression of NLRP3/Caspase‐1 Inflammasome in Human Peripheral Blood Mononuclear Cells. Evidence-based Complementary and Alternative Medicine. 2016(1). 2758140–2758140. 12 indexed citations
19.
Hu, Chung‐Yi, Yanjiao Lu, Jun Yang, et al.. (1993). Intravitreal Pharmacokinetics of Liposome-encapsulated Amikacin in a Rabbit Model. Ophthalmology. 100(11). 1640–1644. 42 indexed citations
20.
Gong, Bing, et al.. (1986). Biochemical and immunological studies on treatment of asthmatic children by means of propagated sensation along channels elicited by meditation.. PubMed. 6(4). 257–62. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026